Skip to content
healthcare.dev

CVS Topical Anesthetic Hemorrhoidal

NDC 51316-250, DIBUCAINE, ointment, from CVS PHARMACY, INC.

Product NDC
51316-250
Status
Listed
Labeler
CVS PHARMACY, INC
Dosage form
OINTMENT
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51316-250 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIBUCAINE10 mg/g

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
51316-250-00513160250001 TUBE in 1 BOX (51316-250-00) / 28 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51316-250 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51316-250 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51316-250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.